“…The study conducted to inform the U.S. Food and Drug Administration’s (FDA) selection of the final graphic warnings utilized self-reported emotional and cognitive reactions, recall, beliefs about the health risks of smoking, and intention to quit as outcomes, which are all explicit measures (Nonnemaker, Choiniere, Farrelly, Kamyab, & Davis, 2015). One small experimental study reported that exposure to the graphic warning labels that were high in emotional reactivity reduced the electrophysiological brain response to smoking cues (Wang, Lowen, Romer, Giorno, & Langleben, 2015), but other recent studies on the impact of the FDA’s final proposed graphic warnings have relied on self-reported explicit outcome measures (Cameron, Pepper, & Brewer, 2013; Cantrell et al, 2013; Hammond, Reid, Driezen, & Boudreau, 2013; Mays et al, 2014; Nonnemaker et al, 2015; Villanti, Cantrell, Pearson, Vallone, & Rath, 2014). …”